ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,964
Screening encounters
3,367
Diagnostic referrals
643
Outstanding pathways
241

Screening pathway

  1. Screening3,367Encounters
  2. Positive finding1,159Documented findings
  3. Referral643Diagnostic referrals
  4. Follow-up758Diagnostic visits
  5. Outcome402Resolved pathways

Stage totals use different units. Pending pathways: 241. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3232 · EXP-3232Synthetic · Site B

Full participant history through 2026-06-15, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-20
  4. · Diagnostic referral · EXP-3232-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Reached
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-3232-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-20

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2964 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4523 · Expanded synthetic participant 4523Site A — Urban Referral Hub
EXP-4526 · Expanded synthetic participant 4526Site D — Community Engagement Programme
EXP-4529 · Expanded synthetic participant 4529Site D — Community Engagement Programme
EXP-4531 · Expanded synthetic participant 4531Site A — Urban Referral Hub
EXP-4533 · Expanded synthetic participant 4533Site E — Resource-Constrained Navigation Programme
EXP-4534 · Expanded synthetic participant 4534Site D — Community Engagement Programme
EXP-4535 · Expanded synthetic participant 4535Site C — Rural Outreach Programme
EXP-4537 · Expanded synthetic participant 4537Site B — Peri-Urban Access Programme
EXP-4539 · Expanded synthetic participant 4539Site D — Community Engagement Programme
EXP-4541 · Expanded synthetic participant 4541Site D — Community Engagement Programme
EXP-4542 · Expanded synthetic participant 4542Site E — Resource-Constrained Navigation Programme
EXP-4544 · Expanded synthetic participant 4544Site E — Resource-Constrained Navigation Programme
EXP-4545 · Expanded synthetic participant 4545Site C — Rural Outreach Programme
EXP-4546 · Expanded synthetic participant 4546Site C — Rural Outreach Programme
EXP-4548 · Expanded synthetic participant 4548Site A — Urban Referral Hub
EXP-4549 · Expanded synthetic participant 4549Site D — Community Engagement Programme
EXP-4551 · Expanded synthetic participant 4551Site B — Peri-Urban Access Programme
EXP-4552 · Expanded synthetic participant 4552Site A — Urban Referral Hub
EXP-4553 · Expanded synthetic participant 4553Site E — Resource-Constrained Navigation Programme
EXP-4554 · Expanded synthetic participant 4554Site D — Community Engagement Programme
EXP-4556 · Expanded synthetic participant 4556Site C — Rural Outreach Programme
EXP-4557 · Expanded synthetic participant 4557Site E — Resource-Constrained Navigation Programme
EXP-4559 · Expanded synthetic participant 4559Site D — Community Engagement Programme
EXP-4560 · Expanded synthetic participant 4560Site C — Rural Outreach Programme
EXP-4562 · Expanded synthetic participant 4562Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1352
HPV DNA
1519
Cytology
496

Navigation activity

Barrier documented
549
Contact attempt
945
Navigation intervention
237
Diagnostic booking
796
Diagnostic visit
758

Documented barriers

Contact difficulty
181
Transport difficulty
169
Appointment coordination
199

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.